Chief Medical Officer (consulting), Quanterix Corp
BIOGRAPHY
APR 13, 2017 1:30 PM PDT
Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers
Presented at:
Molecular Diagnostics Virtual Event Series 2017
Speaker
Abstract
The presentation will describe the principles of the ultra-sensitive single-molecule array (Simoa) developed by Quanterix and the application of the Simoa technology to the development of a toolbox of CNS biomarkers. The presentation will include several case studies across CNS diseases, ranging from traumatic brain injury to Alzheimer's Disease
You May Also Like
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
APR 13, 2017 1:30 PM PDT
Share
Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers
Presented at:
Molecular Diagnostics Virtual Event Series 2017
Loading Comments...